{"publication_id":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","traces":[{"claim_id":"claim_1","claim":"The anti-aging conversation often treats glycation as if the mechanism, biomarker, dietary exposure, diabetes complication literature, and intervention claim were one continuous evidence chain. The current source bundle supports a narrower and more useful split: AGEs are repeatedly connected with oxidative stress, metabolic disease, tissue injury, and molecular aging, but that does not automatically promote any intervention to a longevity endpoint claim.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_2","claim":"A diabetes-focused review links AGEs with oxidative stress in type 2 diabetes, supporting metabolic-damage relevance without generalizing to healthy-aging intervention efficacy. DOI `10.3390/biom5010194`.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_3","claim":"A 2019 review connects oxidative stress, advanced lipoxidation products, and AGEs with aging and age-related diseases, supporting the damage-burden framing. DOI `10.1155/2019/3085756`.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_4","claim":"A 2021 review discusses AGEs and related adducts across aging-related diseases and alcohol-mediated tissue injury, again supporting cross-condition mechanism rather than a single geroprotective treatment claim. DOI `10.1038/s12276-021-00561-7`.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_5","claim":"For longevity triage, glycation should be routed into two separate queues: measurement/source-of-damage evidence on one side, and intervention-outcome evidence on the other. The source bundle is strong enough to justify an alpha memo about the boundary, but not strong enough to publish a broad claim that anti-glycation products slow human aging.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_6","claim":"Direct comparative evidence showing AGE biomarkers add little beyond glucose, renal function, inflammation, or oxidative-stress markers would weaken the measurement-lane claim.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]},{"claim_id":"claim_7","claim":"The fresh longevity signal is not \"AGEs are the cause of aging\". The publishable alpha is the boundary: glycation has enough source support to be a serious aging-damage lane, while intervention claims still need direct endpoint receipts before they should be sold as anti-aging evidence.","candidate_sources":[{"study":"Advanced Glycation End Products in Disease Development and Potential Interventions","doi":"10.3390/antiox14040492","url":null},{"study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","doi":"10.3390/biom5010194","url":null},{"study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","doi":"10.1155/2019/3085756","url":null},{"study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","doi":"10.1038/s12276-021-00561-7","url":null},{"study":"A Role for Advanced Glycation End Products in Molecular Ageing","doi":"10.3390/ijms24129881","url":null}]}]}